Skip to main content
. 2020 Oct 30;11(1):1112–1123. doi: 10.1080/21655979.2020.1831361

Figure 5.

Figure 5.

Validation of SNHG12 expression level in multiple cancers in TCGA cohort. (a) The expression level of SNHG12 in breast invasion carcinoma (BRCA), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), liver hepatocellular carcinoma (LIHC), colon adenocarcinoma (COAD), rectum adenocarcinoma (READ), kidney renal clear cell carcinoma (KIRC), kidney renal papillary cell carcinoma (KIRP), sarcoma (SARC), and stomach adenocarcinoma (STAD). (b) Violin plot implicating SNHG12 expression levels in different pathological stage of human pan-cancers in TCGA cohort. (c) Overall survival plot of SNHG12 in TCGA cohort (n = 9497). (d) Disease-free survival plot of SNHG12 in TCGA cohort (n = 9497)